Politics Eli Lilly’s obesity drug retatrutide clears late-stage diabetes trial Finance News Mar 19, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.Mike Blake |… Read More...
Politics Zealand stock falls 35% after trial setback, CEO remains optimistic Finance News Mar 6, 2026 Wegovy is produced by pharmaceutical company Novo Nordisk and has been approved for specifically for chronic weight… Read More...
Politics Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly Finance News Mar 2, 2026 Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its production… Read More...
Politics Trump angering MAHA with glyphosate order gives Democrats an opening Finance News Feb 27, 2026 An attendee holds a Make America Healthy Again (MAHA) Moms sign at the end of a press conference announcing of the… Read More...
Politics These 4 charts show the scale of Novo Nordisk’s woes Finance News Feb 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe's most valuable company.But… Read More...
Retail After Supreme Court ruling, industries still face higher rates Finance News Feb 23, 2026 The Supreme Court during a rain storm in Washington, Feb. 20, 2026.Annabelle Gordon | Bloomberg | Getty ImagesThe… Read More...
Politics Novo Nordisk stock falls as weight loss drug fails to beat Eli Lilly Finance News Feb 23, 2026 The Novo Nordisk A/S headquarters in Bagsvaerd, Denmark, on Wednesday, Nov. 5, 2025. Nichlas Pollier | Bloomberg |… Read More...
Business More drugs should be over-the-counter Finance News Feb 18, 2026 Food and Drug Administration Commissioner Marty Makary told CNBC that he believes "everything should be over the… Read More...
Business Novo Nordisk faces defining year in the obesity drug market Finance News Feb 16, 2026 Mike Doustdar, CEO of Novo Nordisk, speaks in the Oval Office during an event about weight loss drugs at the White… Read More...
Politics Prices, pipelines and patent cliffs: Inside pharma’s big reset Finance News Feb 13, 2026 This earnings season, Europe's biggest pharma companies posted results ranging from 7% beats to 3% misses — but no… Read More...